491 related articles for article (PubMed ID: 23992479)
1. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
[TBL] [Abstract][Full Text] [Related]
2. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
Mallia P; Footitt J; Sotero R; Jepson A; Contoli M; Trujillo-Torralbo MB; Kebadze T; Aniscenko J; Oleszkiewicz G; Gray K; Message SD; Ito K; Barnes PJ; Adcock IM; Papi A; Stanciu LA; Elkin SL; Kon OM; Johnson M; Johnston SL
Am J Respir Crit Care Med; 2012 Dec; 186(11):1117-24. PubMed ID: 23024024
[TBL] [Abstract][Full Text] [Related]
3. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
4. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
Mallia P; Message SD; Gielen V; Contoli M; Gray K; Kebadze T; Aniscenko J; Laza-Stanca V; Edwards MR; Slater L; Papi A; Stanciu LA; Kon OM; Johnson M; Johnston SL
Am J Respir Crit Care Med; 2011 Mar; 183(6):734-42. PubMed ID: 20889904
[TBL] [Abstract][Full Text] [Related]
5. Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
Footitt J; Mallia P; Durham AL; Ho WE; Trujillo-Torralbo MB; Telcian AG; Del Rosario A; Chang C; Peh HY; Kebadze T; Aniscenko J; Stanciu L; Essilfie-Quaye S; Ito K; Barnes PJ; Elkin SL; Kon OM; Wong WS; Adcock IM; Johnston SL
Chest; 2016 Jan; 149(1):62-73. PubMed ID: 25790167
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
7. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
[TBL] [Abstract][Full Text] [Related]
8. Human rhinovirus infection during naturally occurring COPD exacerbations.
George SN; Garcha DS; Mackay AJ; Patel AR; Singh R; Sapsford RJ; Donaldson GC; Wedzicha JA
Eur Respir J; 2014 Jul; 44(1):87-96. PubMed ID: 24627537
[TBL] [Abstract][Full Text] [Related]
9. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
[TBL] [Abstract][Full Text] [Related]
10. The lung microbiome and viral-induced exacerbations of chronic obstructive pulmonary disease: new observations, novel approaches.
Dickson RP; Huang YJ; Martinez FJ; Huffnagle GB
Am J Respir Crit Care Med; 2013 Nov; 188(10):1185-6. PubMed ID: 24236585
[No Abstract] [Full Text] [Related]
11. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
[No Abstract] [Full Text] [Related]
12. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
Bouquet J; Tabor DE; Silver JS; Nair V; Tovchigrechko A; Griffin MP; Esser MT; Sellman BR; Jin H
Respir Res; 2020 Mar; 21(1):77. PubMed ID: 32228581
[TBL] [Abstract][Full Text] [Related]
13. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
[TBL] [Abstract][Full Text] [Related]
14. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
[TBL] [Abstract][Full Text] [Related]
15. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
Mallia P; Webber J; Gill SK; Trujillo-Torralbo MB; Calderazzo MA; Finney L; Bakhsoliani E; Farne H; Singanayagam A; Footitt J; Hewitt R; Kebadze T; Aniscenko J; Padmanaban V; Molyneaux PL; Adcock IM; Barnes PJ; Ito K; Elkin SL; Kon OM; Cookson WO; Moffat MF; Johnston SL; Tregoning JS
J Allergy Clin Immunol; 2018 Sep; 142(3):815-823.e6. PubMed ID: 29310905
[TBL] [Abstract][Full Text] [Related]
16. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
[TBL] [Abstract][Full Text] [Related]
17. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.
Xiao W; Du LY; Mao B; Miao TW; Fu JJ
BMJ Open; 2019 Nov; 9(11):e034592. PubMed ID: 31690612
[TBL] [Abstract][Full Text] [Related]
18. Lung microbiome dynamics in COPD exacerbations.
Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
[TBL] [Abstract][Full Text] [Related]
19. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
Einarsson GG; Comer DM; McIlreavey L; Parkhill J; Ennis M; Tunney MM; Elborn JS
Thorax; 2016 Sep; 71(9):795-803. PubMed ID: 27146202
[TBL] [Abstract][Full Text] [Related]
20. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
